Euthymics Bioscience
Cambridge, US · Delaware corporation · 1 known investors
Founders & leadership
AM
Anthony McKinneyPresident and Chief Executive Officer
WP
William PappafotopoulosChief Accounting and Administrative Officer
AA
Anthony A. McKinneyExecutive
FP
Franklin P. BymasterExecutive
TA
Thomas A. SheaExecutive
PT
Pierre TranExecutive
Board
CM
Campbell MurrayBoard director
PW
Paul WeissBoard director
BS
DO
Daniel OmsteadBoard director
TB
Timothy BarberichBoard director
JB
Jeffrey BaileyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$24.6M disclosed across 2 rounds · 2010–2017
▶$300KraisedJun 2017 · 7 investors · BiotechnologyRule 506(b)
▶$300KraisedJun 2017 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Timothy BarberichDirector
- Anthony McKinneyExecutive Officer, Director
- Campbell MurrayDirector
- Albert L. SokolExecutive Officer
- Jeffrey BaileyDirector
- William PappafotopoulosExecutive Officer
- Paul WeissDirector
- Brigitte SmithDirector
- Daniel OmsteadDirector
- Offering amount
- $500K
- Amount sold
- $300K
- First sale
- May 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$24.3MraisedMar 2012 · 7 investors · Other TechnologyRule 506(b)
▶$24.3MraisedMar 2012 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul WeissDirector
- Frank GentileDirector
- Anthony A. McKinneyExecutive Officer, Director
- Campbell MurrayDirector
- Andrew BakerDirector
- Timothy J. BarberichDirector
- Franklin P. BymasterExecutive Officer
- Thomas A. SheaExecutive Officer
- Pierre TranExecutive Officer
- Offering amount
- $28M
- Amount sold
- $24.3M
- Minimum investment
- $28.9K
- Proceeds to insiders
- $943K
- First sale
- Jul 2010
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Euthymics Bioscience's investors?
- Euthymics Bioscience's investors include GBS Venture Partners Ltd..
- How much funding has Euthymics Bioscience raised?
- Euthymics Bioscience has disclosed $24.6M raised across 2 rounds.
- Where is Euthymics Bioscience headquartered?
- Euthymics Bioscience is headquartered in Cambridge, US.